BNTX BioNTech SE

USD 84.95 0.00 0
Icon

BioNTech SE (BNTX) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

Hold

Average User
Rating

USD 84.95

0.00 (0.00)%

USD 18.98B

0.85M

USD 111.64(+31.41%)

USD 176.40 (+107.65%)

Icon

BNTX

BioNTech SE (USD)
COMMON STOCK | NSD
USD 84.95
0.00 0
Take a Tour
stockTargetAdvisor

Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

Hold

Average User
Rating

USD 18.98B

USD 176.40 (+107.65%)

USD 84.95

BioNTech SE (BNTX) Stock Forecast

Show ratings and price targets of :
USD 111.64
(+31.41%)

Based on the BioNTech SE stock forecast from 11 analysts, the average analyst target price for BioNTech SE is USD 111.64 over the next 12 months. BioNTech SE’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of BioNTech SE is Bullish , which is based on 11 positive signals and 4 negative signals. At the last closing, BioNTech SE’s stock price was USD 84.95. BioNTech SE’s stock price has changed by +6.07% over the past week, -7.74% over the past month and -21.52% over the last year.

No recent analyst target price found for BioNTech SE
No recent average analyst rating found for BioNTech SE

Company Overview BioNTech SE

BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/I...Read More

https://www.biontech.de

An der Goldgrube 12, Mainz, Germany, 55131

6,133

December

USD

USA

Adjusted Closing Price for BioNTech SE (BNTX)

Loading...

Unadjusted Closing Price for BioNTech SE (BNTX)

Loading...

Share Trading Volume for BioNTech SE Shares

Loading...

Compare Performance of BioNTech SE Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for BNTX

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To BioNTech SE (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc 0.00 (0.00%) USD127.00B 31.94 20.00

ETFs Containing BNTX

Symbol Name BNTX's Weight Expense Ratio Price(Change) Market Cap
GERM
ETFMG Treatments Testing .. 5.09 % 0.68 % 0.00 (0.00%) USD0.01B

Frequently Asked Questions About BioNTech SE (BNTX) Stock

Based on ratings from 11 analysts BioNTech SE's stock is Buy . Stock Target Advisor's fundamental analysis is Bullish . The stock has 12 buy, 1 sell and 9 hold ratings.

Unfortunately we do not have enough data on BNTX's stock to indicate if its a good dividend stock.

Based on targets from 11 analysts, the average taret price for BNTX is USD 111.64 over the next 12 months. The maximum analyst target price is USD 171 while the minimum anlayst target price is USD 87.

BNTX stock's Price/Earning ratio is 157.52. Our analysis grades BNTX stock's Price / Earning ratio at F. This means that BNTX stock's Price/Earning ratio is above 92% of the stocks in the Biotechnology sector in the NSD exchange. Based on this BNTX may be a overvalued for its sector.

The last closing price of BNTX's stock was USD 84.95.

The most recent market capitalization for BNTX is USD 18.98B.

Based on targets from 11 analysts, the average taret price for BNTX is projected at USD 111.64 over the next 12 months. This means that BNTX's stock price may go up by +31.41% over the next 12 months.

Following are ETFs with the highest allocation to BioNTech SE's stock :

GERM

As per our most recent records BioNTech SE has 6,133 Employees.

BioNTech SE's registered address is An der Goldgrube 12, Mainz, Germany, 55131. You can get more information about it from BioNTech SE's website at https://www.biontech.de.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...